Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Atrial Fibrillation / Cerebrovascular Accident Prevention

Indications	Status	Purpose	Phase
DBCOND0000503 (Atrial Fibrillation) DBCOND0027931 (Cerebrovascular Accident)	Active Not Recruiting	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02168829	Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial	Acetylsalicylic acid (DB00945) Rivaroxaban (DB06228)
NCT01938248	Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation	Acetylsalicylic acid (DB00945) Apixaban (DB06605)